Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth -- Data Supplement - Supporting Information -- Proceedings of the National Academy of Sciences

Supporting information for Leong et al. (2003) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.0534764100

Fig. 10.
Increased growth inhibition of Stat3 decoy compared with phosphorothioated antisense oligonucleotides or and epidermal growth factor receptor (EGFR)-specific tyrosine kinase inhibitor. Squamous cell carcinoma of the head and neck (SCCHN) cells (1483) were treated with Stat3 decoy (25 µM) or Stat3 antisense oligonucleotides (12.5 µM), or an EGFR-specific tyrosine kinase inhibitor (PD153035) (100 nM), followed by MTT assay at several time points.